Ruobing Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ruobing Liu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Da Jing
Department of Biomedical Engineering Fourth Military Medical University Xi'an China
1 shared publication - Dan Wang
College of Life Sciences Northwest University Xi'an China
1 shared publication - Jing Cai
College of Basic Medicine Shaanxi University of Chinese Medicine Xianyang China
1 shared publication - Jinghui Huang
Department of Orthopaedics, Xijing Hospital, Fourth Military Medical University, Xi’an, China
1 shared publication - Juan Liu
School of Biomedical Engineering, The Air Force Military Medical University, 710032 Xi’an, Shaanxi, China
1 shared publication - Maogang Jiang
Department of Biomedical Engineering Fourth Military Medical University Xi'an China
1 shared publication
Latest Publications
- 11 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (3) , e70385
Whole‐body vibration protects against chronic high‐altitude hypoxic bone loss by regulating the nitric oxide/ HIF ‐1α axis in osteoblasts
The hypobaric hypoxia environment found at high altitudes imposes various reversible and irreversible detrimental effects on living organisms. Accumulating evidence suggests that hypobaric hypoxia negatively impacts skeleton health by diminishing bone quality and disrupting bone microarchitecture. However, therapeutic strategies to counteract this bone loss remain limited. This study investigates the impact of whole‐body vibration (WBV) stimulation on skeletal health of rats continuously exposed to simulated hypobaric hypoxia environment at an altitude of 4500 m for 6 weeks. We found that WBV stimulation at 30 Hz and 0.3 g significantly improved femoral bone mass, microarchitecture, and biomechanical properties in rats exposed to chronic hypobaric hypoxia. Additionally, in vitro studies demonstrated that WBV enhanced osteogenic potential and activity in primary osteoblasts under hypoxia conditions. It also reduced levels of hypoxia‐inducible factor 1α (HIF‐1α), a key transcription factor involved in cellular response to hypoxia. Conversely, overexpression of HIF‐1α significantly inhibited cellular differentiation and osteogenesis in osteoblasts exposed to WBV stimulation under hypoxic conditions. Furthermore, WBV stimulation led to a significant increase in nitric oxide (NO) concentrations in osteoblasts during hypoxic exposure. In vitro experiments showed that blocking of NO synthesis with L‐NAME impeded WBV‐stimulated osteogenic activity in hypoxia‐exposed osteoblasts. In vivo studies demonstrated that inhibiting NO synthesis similarly abolished the positive impact of WBV on bone microarchitecture and biomechanical properties under hypobaric hypoxia. Collectivity, our findings indicate that WBV protects against hypobaric hypoxia‐induced bone loss by regulating the NO/HIF‐1α axis in osteoblasts, and reveal its clinical potential as a promising non‐invasive approach.
- 11 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (3) , e70385
Whole‐body vibration protects against chronic high‐altitude hypoxic bone loss by regulating the nitric oxide/ HIF ‐1α axis in osteoblasts
The hypobaric hypoxia environment found at high altitudes imposes various reversible and irreversible detrimental effects on living organisms. Accumulating evidence suggests that hypobaric hypoxia negatively impacts skeleton health by diminishing bone quality and disrupting bone microarchitecture. However, therapeutic strategies to counteract this bone loss remain limited. This study investigates the impact of whole‐body vibration (WBV) stimulation on skeletal health of rats continuously exposed to simulated hypobaric hypoxia environment at an altitude of 4500 m for 6 weeks. We found that WBV stimulation at 30 Hz and 0.3 g significantly improved femoral bone mass, microarchitecture, and biomechanical properties in rats exposed to chronic hypobaric hypoxia. Additionally, in vitro studies demonstrated that WBV enhanced osteogenic potential and activity in primary osteoblasts under hypoxia conditions. It also reduced levels of hypoxia‐inducible factor 1α (HIF‐1α), a key transcription factor involved in cellular response to hypoxia. Conversely, overexpression of HIF‐1α significantly inhibited cellular differentiation and osteogenesis in osteoblasts exposed to WBV stimulation under hypoxic conditions. Furthermore, WBV stimulation led to a significant increase in nitric oxide (NO) concentrations in osteoblasts during hypoxic exposure. In vitro experiments showed that blocking of NO synthesis with L‐NAME impeded WBV‐stimulated osteogenic activity in hypoxia‐exposed osteoblasts. In vivo studies demonstrated that inhibiting NO synthesis similarly abolished the positive impact of WBV on bone microarchitecture and biomechanical properties under hypobaric hypoxia. Collectivity, our findings indicate that WBV protects against hypobaric hypoxia‐induced bone loss by regulating the NO/HIF‐1α axis in osteoblasts, and reveal its clinical potential as a promising non‐invasive approach.